Aurora Cannabis Inc T.ACB

Alternate Symbol(s): T.ACB.WS.U | ACB

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by longonMJon Aug 25, 2018 1:07am

184 Views

Post# 28516418

RE:Top Five Canadian Cannabis Company Sales Estimates 2019

Wow, How old is this article?

It talks about combining the sales of Aurora with CanniMed due to their recent takeover of CMED. It then shows MedReleaf separately in the #5 position since I assume it had not yet been taken over by Aurora at the time this article was written. It also places Cannabis Wheaton in the #4 position, even though this company had changed its name to Auxly Cannabis quite a few months ago.

All I can say is if they can't get the basic facts right, I highly doubt the accuracy of their sales forecast for next year.

Kevelle wrote:
Top Five Canadian Cannabis Company Sales Estimates 2019

The following five companies are set to rake in the highest estimated sales come 2019. 1. Aurora Cannabis: $304.8 million In terms of total sales, Aurora Cannabis may be the likeliest to breach $300 million in 2019, per Wall Street estimates. The above revenue figure includes an estimated $110 million in annual...Continue Reading →